PPT-Treatment Options for Stroke Prevention in Nonvalvular Atri

Author : min-jolicoeur | Published Date : 2017-11-15

Percutaneous Left Atrial Appendage LAA Exclusion Aaditya Vora MD Cardiac Electrophysiologist Baptist heart specialists Disclosures None gt 33M people with AF Worldwide

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Treatment Options for Stroke Prevention ..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Treatment Options for Stroke Prevention in Nonvalvular Atri: Transcript


Percutaneous Left Atrial Appendage LAA Exclusion Aaditya Vora MD Cardiac Electrophysiologist Baptist heart specialists Disclosures None gt 33M people with AF Worldwide 1 Many patients are unprotected. Branko. N . Huisa. M.D.. Assistant Professor of Neurology. UNM Stroke Center. THE END!. CHANGABLE. . Blood pressure. Diabetes Mellitus. . Hyperlipidemia. . Atrial. fibrillation. Nicotine. Drug abuse. MD, DM, DNB, MNAMS. Consultant Neurologist, . Manipal. Goa Hospital. STROKE: . AN OVERVIEW. Stroke: Brain Attack. Sudden . loss of function of a part of the brain. Due to a problem with blood supply. 2014 . DOL Safety Training Stand Down. Heather Martin, MSPH . 2. Heat Illness: Matter of Life or Death. Heat is the leading weather-related killer in the US- more than hurricanes, tornadoes, floods, lightning or any other weather event combined. . Presented by: Carrie Miller, MPH. . Ahmed . Alquthami, MD, MHSA. Introduction. Hypertension & . Stroke. Background. Pathophysiology. Significance. Descriptive Epidemiology. Causes. Prevention and control measures. Mortality Risks . in . Elderly Medicare Beneficiaries . Treated . with Dabigatran . or Rivaroxaban . for . Nonvalvular. Atrial Fibrillation. To compare risks of thromboembolic stroke, intracranial hemorrhage, major . Goals of Presentation. What is a stroke?. Types of stroke. Warning signs of stroke. Why did I have a stroke?. Are there treatments for stroke?. How can I prevent a stroke?. What Is a Stroke?. Interruption of normal blood flow to the brain. Lama Al-Khoury, MD. Clinical Assistant Professor. Neurology. UCI Medical Center. Dec 8. th. , 2014. Stroke Epidemiology. Incidence of stroke in . USA. is 795,000/ year in the United States of America. DOL Safety Training Stand Down. Heather Martin, MSPH . 2. Heat Illness: Matter of Life or Death. Heat is the leading weather-related killer in the US- more than hurricanes, tornadoes, floods, lightning or any other weather event combined. . Clinical picture of TIA. Neurologic deficits are . completelly and spontaneously reversible. . in less than 24 hours. No signs on CT. TIA is usually characterized by focal neurological symptoms. . There are 2 main groups of TIA’s symptoms:. Assist. Lect. . Shaymaa. . Hasan. Abbas. DESIRED TREATMENT OUTCOMES. The short-term goals for the treatment of hemorrhagic stroke include rapid . neurointensive. care treatment to maintain adequate oxygenation, breathing, and circulation. Management of increased intracranial pressure and blood pressure (BP) are important in the acute setting.. Assist.Lect. . . Shaymaa. . Hasan. Abbas. DESIRED TREATMENT OUTCOMES. The short-term goals of treatment for acute ischemic stroke include reducing secondary brain damage by re-establishing and maintaining adequate perfusion to marginally ischemic areas of the brain and to protect these areas from the effects of ischemia (i.e., . Current and Future. Published in journal of European neurology. On august 2022. INTRODUCTION. Despite progress in the . understanding of the pathophysiological mechanisms underlying stroke over the past 3 decades, concerning early diagnosis and the development of protocols that have reduced the door-to-needle time for acute ischemic stroke (AIS) treatment, several clinical gaps remain unsolved.. GPhC. National NHS Liaison. Since 2013 . pharmacists from . Interface Clinical Services have reviewed nearly . 300,000. AF patients across more than . 2,000. . sites. Interface have been supporting . Michela Rosso. CANCER AND STROKE. CANCER and VTE. LMWH . for at least 3 to 6 months . has . been the standard of care in treating cancer-associated . VTE [4]. .. Historically. , . LMWH . have been preferred for cancer-associated VTE .

Download Document

Here is the link to download the presentation.
"Treatment Options for Stroke Prevention in Nonvalvular Atri"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents